Document is current

Article History

Received: 13 April 2023

Accepted: 15 September 2023

First Online: 26 September 2023

Declarations

:

: This study was conducted in compliance with Good Clinical Practice guidelines, including International Conference on Harmonization Guidelines. In addition, all applicable local laws and regulatory requirements were adhered to throughout the study. Before recruiting participants, all study documents for this qualitative study were reviewed and approved by an independent Institutional Review Board. All participants were required to sign and date the electronic informed consent form as part of the screening survey before conducting study activities. Copies of these signed documents are held by Clinical Outcomes Solutions (COS). All participants were also reminded that they could withdraw their consent at any time without compromising their clinical care and knowing they would still receive participation compensation for tasks they had completed. All data collected and processed for this study were managed by COS with adequate precautions to ensure the confidentiality of the data and following applicable national and/or local laws and regulations on personal data protection. All study‐related records and documents, including audio and video recordings, are held on COS’s secure server.

: Not applicable.

: JAR, CS, LR, and CB are employees of Clinical Outcomes Solutions, which received funding to conduct this research. SW, EB, RP, and SS are employees of Applied Therapeutics which funded this study.